A forum for researchers, students and applicants in the field of cyclodextrin technology
Cyclodextrins (CDs), the therapeutic candidates for Niemann–Pick disease type C (NPC), function dually as a shuttle and sink that catalytically
Fosaprepitant has been initially approved in 2008 in the USA. In August, 2023, an improved composition also containing SBECD has
Huntington’s disease (HD) is a progressive inherited neurodegenerative disease caused by a CAG repeat expansion in the huntingtin gene, which
This study comprehensively evaluates three generations of thiolated cyclodextrins (CDs). Free thiol groups of thiolated γ-CDs (CD-SH) were S-protected with
This study aimed to evaluate the effect of thiolated α-cyclodextrin (α-CD-SH) on the cellular uptake of its payload. For this
Cyclodextrins have been widely employed for drug delivery systems (DDSs) in which drugs are selectively delivered to a target site
The present thematic issue aims to offer a wide and advanced collection of papers on the use of cyclodextrins as
Professor Makoto Komiyama (born in 1947) is a world-famous nucleic acid chemist who is known for using artificial approaches to
The inclusion complexes of several large-ring cyclodextrins with a number of monovalent ligands (five or six adamantane molecules; CDn/mADA; n
In this study, the effect of 12 CD derivatives was investigated on stabilizing the supersaturation by inhibiting the crystallization of
